BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khanna S, Kraft CS. Fecal Microbiota Transplantation: Tales of Caution. Clin Infect Dis 2021;72:e881-2. [PMID: 32991697 DOI: 10.1093/cid/ciaa1492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu LY, Huang BW, Zhang XL, Zhu N. Progress in application of probiotics, prebiotics, and synbiotics in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2022; 30(8): 375-380 [DOI: 10.11569/wcjd.v30.i8.375] [Reference Citation Analysis]
2 Khanna S, Kraft CS. The interplay of SARS-CoV-2 and Clostridioides difficile infection. Future Microbiol 2021;16:439-43. [PMID: 33847139 DOI: 10.2217/fmb-2020-0275] [Reference Citation Analysis]
3 Khanna S. Advances in Clostridioides difficile therapeutics. Expert Rev Anti Infect Ther 2021;19:1067-70. [PMID: 33427531 DOI: 10.1080/14787210.2021.1874919] [Reference Citation Analysis]
4 Khanna S. A defined microbiome therapeutic prevents recurrent Clostridioides difficile. Lancet Gastroenterol Hepatol 2021;6:255-6. [PMID: 33631103 DOI: 10.1016/S2468-1253(21)00011-X] [Reference Citation Analysis]
5 Sezer A, Halilović-Alihodžić M, Vanwieren AR, Smajkan A, Karić A, Djedović H, Šutković J. A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives. J Genet Eng Biotechnol 2022;20:78. [PMID: 35608704 DOI: 10.1186/s43141-022-00353-0] [Reference Citation Analysis]
6 Khanna S. Microbiota restoration for recurrent Clostridioides difficile: Getting one step closer every day! J Intern Med 2021;290:294-309. [PMID: 33856727 DOI: 10.1111/joim.13290] [Reference Citation Analysis]